Literature DB >> 2570328

Hyper-IgE syndrome and H2-receptor blockade.

R A Thompson, D S Kumararatne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2570328     DOI： 10.1016/s0140-6736(89)90759-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  The hyperimmunoglobulinaemia E and recurrent infections syndrome in an adult.

Authors:  D Honeybourne; S Maxwell
Journal:  Thorax       Date:  1991-03       Impact factor: 9.139

2.  The effect of ranitidine on cellular immunity in patients with multiple myeloma.

Authors:  H J Nielsen; H Nielsen; F Moesgaard; N Tvede; K Klarlund; B Mansa; A Drivsholm
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

Review 3.  The hyper-IgE syndromes.

Authors:  Alexandra F Freeman; Steven M Holland
Journal:  Immunol Allergy Clin North Am       Date:  2008-05       Impact factor: 3.479

Review 4.  Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes.

Authors:  Alexandra F Freeman; Steven M Holland
Journal:  Pediatr Res       Date:  2009-05       Impact factor: 3.756

Review 5.  The hyperimmunoglobulin E syndrome--clinical manifestation diversity in primary immune deficiency.

Authors:  Aleksandra Szczawinska-Poplonyk; Zdzislawa Kycler; Barbara Pietrucha; Edyta Heropolitanska-Pliszka; Anna Breborowicz; Karolina Gerreth
Journal:  Orphanet J Rare Dis       Date:  2011-11-15       Impact factor: 4.123

6.  STAT3-Mediated Transcriptional Regulation of Osteopontin in STAT3 Loss-of-Function Related Hyper IgE Syndrome.

Authors:  Shubham Goel; Smrity Sahu; Ranjana W Minz; Surjit Singh; Deepti Suri; Young M Oh; Amit Rawat; Shobha Sehgal; Biman Saikia
Journal:  Front Immunol       Date:  2018-05-17       Impact factor: 7.561
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.